129 related articles for article (PubMed ID: 12769699)
1. Review in quantitative structure activity relationships on lipoxygenase inhibitors.
Eleni P; Dimitra HL
Mini Rev Med Chem; 2003 Aug; 3(5):487-99. PubMed ID: 12769699
[TBL] [Abstract][Full Text] [Related]
2. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217
[TBL] [Abstract][Full Text] [Related]
3. Quantitative structure activity relationship (QSAR) analysis of substituted 4-oxothiazolidines and 5-arylidines as lipoxygenase inhibitors.
Choudhary AN; Kumar A; Juyal V
Mini Rev Med Chem; 2010 Jul; 10(8):705-14. PubMed ID: 20412041
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
5. Review, reevaluation, and new results in quantitative structure-activity studies of anticonvulsants.
Hadjipavlou-Litina D
Med Res Rev; 1998 Mar; 18(2):91-119. PubMed ID: 9513950
[TBL] [Abstract][Full Text] [Related]
6. Chalcones in cancer: understanding their role in terms of QSAR. II part.
Repanas A; Katsori AM; Hadjipavlou-Litina D
Mini Rev Med Chem; 2013 Jun; 13(7):952-70. PubMed ID: 22876949
[TBL] [Abstract][Full Text] [Related]
7. Active site characterization and structure based 3D-QSAR studies on non-redox type 5-lipoxygenase inhibitors.
Ul-Haq Z; Khan N; Zafar SK; Moin ST
Eur J Pharm Sci; 2016 Jun; 88():26-36. PubMed ID: 27044904
[TBL] [Abstract][Full Text] [Related]
8. Current trends in quantitative structure activity relationships on FXa inhibitors: evaluation and comparative analysis.
Kontogiorgis CA; Hadjipavlou-Litina D
Med Res Rev; 2004 Nov; 24(6):687-747. PubMed ID: 15250038
[TBL] [Abstract][Full Text] [Related]
9. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
10. Rational Use of Heterogeneous Data in Quantitative Structure-Activity Relationship (QSAR) Modeling of Cyclooxygenase/Lipoxygenase Inhibitors.
Lagunin AA; Geronikaki A; Eleftheriou P; Pogodin PV; Zakharov AV
J Chem Inf Model; 2019 Feb; 59(2):713-730. PubMed ID: 30688458
[TBL] [Abstract][Full Text] [Related]
11. Chromones: A Promising Ring System for New Anti-inflammatory Drugs.
Silva CF; Pinto DC; Silva AM
ChemMedChem; 2016 Oct; 11(20):2252-2260. PubMed ID: 27630077
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
[TBL] [Abstract][Full Text] [Related]
13. Current trends in QSAR on NO donors and inhibitors of nitric oxide synthase (NOS)*.
Kontogiorgis CA; Hadjipavlou-Litina D
Med Res Rev; 2002 Jul; 22(4):385-418. PubMed ID: 12111751
[TBL] [Abstract][Full Text] [Related]
14. Structural modifications of coumarin derivatives: Determination of antioxidant and lipoxygenase (LOX) inhibitory activity.
Roussaki M; Zelianaios K; Kavetsou E; Hamilakis S; Hadjipavlou-Litina D; Kontogiorgis C; Liargkova T; Detsi A
Bioorg Med Chem; 2014 Dec; 22(23):6586-6594. PubMed ID: 25456384
[TBL] [Abstract][Full Text] [Related]
15. QSAR study on 5-lipoxygenase inhibitors using distance-based topological indices.
Agrawal VK; Bano S; Khadikar PV
Bioorg Med Chem; 2003 Dec; 11(24):5519-27. PubMed ID: 14642596
[TBL] [Abstract][Full Text] [Related]
16. QSAR classification-based virtual screening followed by molecular docking studies for identification of potential inhibitors of 5-lipoxygenase.
Shameera Ahamed TK; Rajan VK; Sabira K; Muraleedharan K
Comput Biol Chem; 2018 Dec; 77():154-166. PubMed ID: 30321850
[TBL] [Abstract][Full Text] [Related]
17. QSAR models on H
Pontiki E; Hadjipavlou-Litina D
J Biomol Struct Dyn; 2017 Apr; 35(5):968-1005. PubMed ID: 26982393
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives.
Srivastava P; Vyas VK; Variya B; Patel P; Qureshi G; Ghate M
Bioorg Chem; 2016 Aug; 67():130-8. PubMed ID: 27376460
[TBL] [Abstract][Full Text] [Related]
19. Cytokines in terms of QSAR. Review, evaluation and comparative studies.
Konstantinidou M; Hadjipavlou-Litina D
SAR QSAR Environ Res; 2013 Nov; 24(11):883-962. PubMed ID: 24099567
[TBL] [Abstract][Full Text] [Related]
20. Chalcones in cancer: understanding their role in terms of QSAR.
Katsori AM; Hadjipavlou-Litina D
Curr Med Chem; 2009; 16(9):1062-81. PubMed ID: 19275612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
